Participated · Equity · Feb 2026

ATRO Medical is a Netherlands-based clinical-stage orthopedic medical device company focused on addressing post-meniscectomy pain syndrome with its flagship Artimis Meniscus Prosthesis. The implant is designed to restore joint biomechanics, alleviate pain, and delay osteoarthritis progression for patients who have undergone meniscus removal. The company has reached a key clinical milestone with its latest prosthesis design and is currently conducting ongoing studies in affected patients. Recent activities include strengthening its intellectual-property portfolio and joining the PlugAndPlay Health incubator in the United States, broadening its international exposure. To support upcoming pivotal trials in both the U.S. and Europe, ATRO Medical is optimizing manufacturing, regulatory readiness, and clinical operations. A new leadership structure features Maarten van der Zanden as CEO, Anita Brinks as COO, and founder Tony van Tienen as Chief Medical Officer. The firm also plans to open a share funding campaign on the Eyevestor platform to allow patient and private-investor participation in its next development stage.